Fig. 1From: Clinical, humanistic, and economic burden of severe hemophilia B in the United States: Results from the CHESS US and CHESS US+ population surveysAnnual FIX usage (a) and costs (b). EHL extended half-life, SHL standard half-lifeBack to article page